Cases 11 - 20 of 35
Impax Laboratories Inc. et al v. Lannett Holdings Inc. et al
as 1:2014cv00999
Plaintiff:
Impax Laboratories Inc. , AstraZeneca AB and AstraZeneca UK Limited
Defendant:
Lannett Holdings Inc. and Lannett Company Inc.
Cause Of Action: 35 U.S.C. § 271
Impax Laboratories Inc. et al v. Lannett Holdings Inc. et al
as 1:2014cv00984
Plaintiff:
Impax Laboratories Inc. and AstraZeneca AB
Defendant:
Lannett Holdings Inc. and Lannett Company Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Impax Laboratories Inc.
as 1:2013cv01158
Plaintiff:
Pfizer Inc. and UCB Pharma GmbH
Defendant:
Impax Laboratories Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Sandoz Inc., et al
as 1:2013cv01110
Defendant:
Amerigen Pharmaceuticals Inc., Accord Healthcare Inc. USA, Lupin Ltd. and others
Plaintiff:
Pfizer Inc. and UCB Pharma GmbH
Cause Of Action: 35 U.S.C. § 271
Acura Pharmaceuticals Inc. v. Impax Laboratories Inc.
as 1:2012cv01371
Plaintiff:
Acura Pharmaceuticals Inc.
Defendant:
Impax Laboratories Inc. and King Pharmaceuticals Research & Development, Inc.
Thirdparty_plaintiff:
Impax Laboratories Inc.
Thirdparty_defendant:
King Pharmaceuticals Research & Development, Inc.
Counter_claimant:
Impax Laboratories Inc.
Counter_defendant:
Acura Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Avanir Pharmaceuticals Inc. v. Impax Laboratories Inc.
as 1:2012cv01298
Plaintiff:
Avanir Pharmaceuticals Inc.
Defendant:
Impax Laboratories Inc.
Counter_claimant:
Impax Laboratories Inc.
Counter_defendant:
Avanir Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Cephalon Inc. et al v. Impax Laboratories Inc.
as 1:2011cv01152
Plaintiff:
Cephalon Inc. and CIMA Labs Inc.
Defendant:
Impax Laboratories Inc.
Counter_claimant:
Impax Laboratories Inc.
Counter_defendant:
CIMA Labs Inc. and Cephalon Inc.
Cause Of Action: 35 U.S.C. § 271
GlaxoSmithKline LLC v. Mylan Inc. et al
as 1:2011cv00789
Plaintiff:
GlaxoSmithKline LLC
Defendant:
Mylan Inc. , Mylan Pharmaceuticals Inc. and Impax Laboratories Inc.
Counter_claimant:
Mylan Pharmaceuticals Inc. , Mylan Inc. and Impax Laboratories Inc.
Counter_defendant:
GlaxoSmithKline LLC
Cause Of Action: 35 U.S.C. § 271
Avanir Pharmaceuticals Inc. et al v. Impax Laboratories Inc.
as 1:2011cv00757
Plaintiff:
Avanir Pharmaceuticals Inc. , Avanir Holding Company and Center for Neurologic Study
Defendant:
Impax Laboratories Inc.
Cause Of Action: 35 U.S.C. § 271
Galderma Laboratories Inc. et al v. Impax Laboratories Inc.
as 1:2011cv00477
Plaintiff:
Galderma Laboratories Inc. , Galderma Laboratories LP and Supernus Pharmaceuticals Inc.
Defendant:
Impax Laboratories Inc.
Counter_claimant:
Impax Laboratories Inc.
Counter_defendant:
Galderma Laboratories Inc. , Galderma Laboratories LP and Supernus Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
